Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Official URL: https://nshr-uat.sha.go.ke/fhir/ValueSet/nccp-cancer-primary-site-vs | Version: 0.1.0 | ||||
| Active as of 2026-06-04 | Computable Name: CancerPrimarySiteVS | ||||
Anatomical primary site codes for malignancies, aligned with ICD-10.
References
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs version 📦0.1.0
Expansion performed internally based on codesystem Kenya Cancer Primary Site Code System v0.1.0 (CodeSystem)
This value set contains 35 concepts
| System | Code | Display (en) | Definition | JSON | XML |
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | BREAST | Breast | C50 — Malignant neoplasm of breast. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | CERVIX-UTERI | Cervix Uteri | C53 — Malignant neoplasm of cervix uteri. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | CORPUS-UTERI | Corpus Uteri | C54 — Malignant neoplasm of corpus uteri. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | OVARY | Ovary | C56 — Malignant neoplasm of ovary. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | PROSTATE | Prostate | C61 — Malignant neoplasm of prostate. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | COLON | Colon | C18 — Malignant neoplasm of colon. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | RECTUM | Rectum | C20 — Malignant neoplasm of rectum. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | OESOPHAGUS | Oesophagus | C15 — Malignant neoplasm of oesophagus. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | STOMACH | Stomach | C16 — Malignant neoplasm of stomach. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | LIVER | Liver and Intrahepatic Ducts | C22 — Malignant neoplasm of liver. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | PANCREAS | Pancreas | C25 — Malignant neoplasm of pancreas. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | LUNG | Lung and Bronchus | C34 — Malignant neoplasm of bronchus and lung. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | LARYNX | Larynx | C32 — Malignant neoplasm of larynx. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | NASOPHARYNX | Nasopharynx | C11 — Malignant neoplasm of nasopharynx. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | ORAL-CAVITY | Oral Cavity and Pharynx | C00–C14 — Malignant neoplasm of lip, oral cavity and pharynx. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | THYROID | Thyroid Gland | C73 — Malignant neoplasm of thyroid. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | KIDNEY | Kidney | C64 — Malignant neoplasm of kidney. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | BLADDER | Urinary Bladder | C67 — Malignant neoplasm of bladder. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | SKIN-MELANOMA | Skin — Melanoma | C43 — Malignant melanoma of skin. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | SKIN-NON-MELANOMA | Skin — Non-melanoma | C44 — Other malignant neoplasms of skin. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | BRAIN-CNS | Brain and CNS | C71–C72 — Malignant neoplasm of brain / CNS. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | BONE | Bone and Articular Cartilage | C40–C41 — Malignant neoplasm of bone. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | SOFT-TISSUE | Soft Tissue / Sarcoma | C49 — Malignant neoplasm of connective and soft tissue. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | BURKITT-LYMPHOMA | Burkitt Lymphoma | C83.7 — Burkitt lymphoma. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | HODGKIN-LYMPHOMA | Hodgkin Lymphoma | C81 — Hodgkin lymphoma. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | NON-HODGKIN-LYMPHOMA | Non-Hodgkin Lymphoma | C82–C86 — Non-Hodgkin lymphoma. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | LEUKAEMIA-ALL | Leukaemia — ALL | C91.0 — Acute lymphoblastic leukaemia. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | LEUKAEMIA-AML | Leukaemia — AML | C92.0 — Acute myeloid leukaemia. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | LEUKAEMIA-CLL | Leukaemia — CLL | C91.1 — Chronic lymphocytic leukaemia. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | LEUKAEMIA-CML | Leukaemia — CML | C92.1 — Chronic myeloid leukaemia. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | MULTIPLE-MYELOMA | Multiple Myeloma | C90.0 — Multiple myeloma. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | KAPOSI-SARCOMA | Kaposi Sarcoma | C46 — Kaposi sarcoma. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | WILMS-TUMOUR | Wilms Tumour (Nephroblastoma) | C64 — Malignant neoplasm of kidney (paediatric). | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | RETINOBLASTOMA | Retinoblastoma | C69.2 — Retinoblastoma. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs | OTHER | Other / Not Specified | Primary site not listed or not specified. |